Nano‐Strategies for Lignin Biomaterials toward Cancer Therapy
Advanced Healthcare Materials · 2023
DOI: 10.1002/adhm.202300024 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Thenapakiam Sathasivam und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Sustainability for Chemicals, Energy and Environment (ISCE2), The Agency for Science, Technology and Research (A*STAR), 2 Fusionopolis W…. Hauptthemen laut MEDLINE: Nanostructures, Neoplasms. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 209 Literaturangaben. Gefördert von: Connecticut Development Authority, Agency for Science, Technology and Research.
Abstract (Originalsprache)
Lignin is a nontoxic and biocompatible biopolymer with many promising characteristics, including a high tensile strength and antioxidant properties. This natural polymer can be processed through several chemical methods and modified into lignin nanomaterials for potential biomedical applications. This review summarizes the latest developments in nanolignin (NL)‐based biomaterials for cancer therapy; various NL applications related to cancer therapy are considered, including drug and gene delivery, biosensing, bioimaging, and tissue engineering. The manuscript also outlines the potential use of these materials to improve the therapeutic potency of chemotherapeutic drugs by decreasing their dose and reducing their adverse effects. Due to its high surface area‐to‐volume ratio and the easy modification of its chemical components, NL could serve as an appropriate matrix for the binding and controlled release of various pharmaceutical agents. Moreover, the challenges in the utilization of NL‐based materials for cancer therapy are discussed, along with the prospects of advances in such nanomaterials for medical research applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Sustainability for Chemicals, Energy and Environment (ISCE2), The Agency for Science, Technology and Research (A*STAR), 2 Fusionopolis Way, Innovis, #08-03, Singapore, 138634, Singapore.
- Institute of Materials Research and Engineering (IMRE), The Agency for Science, Technology and Research (A*STAR), 2 Fusionopolis Way, Innovis, #08-03, Singapore, 138634, Singapore.
- Cell Migration and Signaling Laboratory, Bioscience Program, Division of Biological and Environmental Science and Engineering, King Abdullah University of Science and Technology (KAUST), Thuwal, 23955-6900, Saudi Arabia.
- School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 21 Nanyang Link, Singapore, 637371, Singapore.
ORCID-Profile: Dan Kai
Förderung
- Connecticut Development Authority
- Agency for Science, Technology and Research
Zitieren
APA
Sathasivam, T., Kai, J., Sugiarto, S., Yu, Y., Soo, D. X. Y., Zhu, Q., Merzaban, J., & Kai, D. (2023). Nano‐Strategies for Lignin Biomaterials toward Cancer Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202300024
Vancouver
Sathasivam T, Kai J, Sugiarto S, Yu Y, Soo DXY, Zhu Q, et al. Nano‐Strategies for Lignin Biomaterials toward Cancer Therapy. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202300024
BibTeX
@article{Sathasivam2023,
author = {Sathasivam, Thenapakiam and Kai, Jing and Sugiarto, Sigit and Yu, Yong and Soo, Debbie Xiang Yun and Zhu, Qiang and Merzaban, Jasmeen and Kai, Dan},
title = {Nano‐Strategies for Lignin Biomaterials toward Cancer Therapy},
journal = {Advanced Healthcare Materials},
year = {2023},
doi = {10.1002/adhm.202300024}
}
EUVIMED